GBIM
GLOBEIMMUNE INC by GlobeImmune, Inc. (GBIM)
$00
About GLOBEIMMUNE INC by GlobeImmune, Inc. (GBIM)
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
1,200
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
GLOBEIMMUNE INC by GlobeImmune, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
1,200
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--